PERTUSSIS RESURGENCE ASSOCIATED WITH PERTACTIN-DEFICIENT AND GENETICALLY DIVERGENT BORDETELLA PERTUSSIS ISOLATES IN ISRAEL

被引：13

作者：

Bamberger, Ellen ^{[1
,2
]}

Abu Raya, Bahaa ^{[2
,3
]}

Cohen, Lyora ^{[1
]}

Golan-Shany, Orit ^{[1
]}

Davidson, Sima ^{[4
]}

Geffen, Yuval ^{[4
]}

Srugo, Isaac ^{[1
,2
,3
]}

机构：

[1] Bnai Zion Med Ctr, Clin Microbiol Lab, IL-31048 Haifa, Israel

[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel

[3] Bnai Zion Med Ctr, Dept Pediat, IL-31048 Haifa, Israel

[4] Rambam Med Ctr, Lab Clin Bacteriol, Haifa, Israel

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2015年 / 34卷 / 08期

关键词：

Pertussis; genotype; Israel; INCREASE;

D O I：

10.1097/INF.0000000000000753

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The Bordetella pertussis polymerase chain reaction positivity rate changed after additional diphtheria-tetanus-acellular pertussis boosters in 2005 and 2008, 9.8%, 13.4%, 22% and 15.2% in 2010, 2011, 2012 and 2013, P < 0.001, respectively. New pulsed-field gel electrophoresis profiles were detected between 2009 and 2012. The proportion of pertactin-deficient isolates increased over time, 6.6% versus 7.1% versus 33.3% during 2005-2006, 2011-2012 and 2013-2014, P < 0.03, respectively.

引用

页码：898 / 900

页数：3

共 50 条

[31] Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica
Boursaux-Eude, C
Guiso, N
[J]. INFECTION AND IMMUNITY, 2000, 68 (08) : 4815 - 4817
[32] Crucial role of antibodies to pertactin in Bordetella pertussis immunity
Hellwig, SMM
Rodriguez, ME
Berbers, GAM
de Winkel, JGJV
Mooi, FR
[J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05): : 738 - 742
[33] Bordetella pertussis isolates, Finland
Mäkinen, J
Mertsola, J
Mooi, FR
Van Amersfoorth, S
Arvilommi, H
Viljanen, MK
He, QS
[J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 183 - 184
[34] New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates
Bouchez, Valerie
Hegerle, Nicolas
Strati, Francesco
Njamkepo, Elisabeth
Guiso, Nicole
[J]. VACCINES, 2015, 3 (03): : 751 - 770
[35] Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative
Solans, Luis
Debrie, Anne-Sophie
Coutte, Loic
Locht, Camille
[J]. VACCINE, 2021, 39 (21) : 2843 - 2849
[36] High prevalence of currently circulating Bordetella pertussis isolates not producing vaccine antigen pertactin in Slovenia
Kastrin, T.
Barkoff, A-M.
Paragi, M.
Vitek, M. G.
Mertsola, J.
He, Q.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (02) : 258 - 260
[37] CRYSTALLOGRAPHIC CHARACTERIZATION OF PERTACTIN, A MEMBRANE-ASSOCIATED PROTEIN FROM BORDETELLA-PERTUSSIS
EMSLEY, P
MCDERMOTT, G
CHARLES, IG
FAIRWEATHER, NF
ISAACS, NW
[J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (02) : 772 - 773
[38] Analysis of BvgA activation of the pertactin gene promoter in Bordetella pertussis
Kinnear, SM
Boucher, PE
Stibitz, S
Carbonetti, NH
[J]. JOURNAL OF BACTERIOLOGY, 1999, 181 (17) : 5234 - 5241
[39] The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China
Yao, Kaihu
Deng, Jikui
Ma, Xiang
Dai, Wenkui
Chen, Qiang
Zhou, Kai
Ye, Jinyan
Shi, Wei
Wang, Heping
Li, Dongfang
Wang, Hongmei
Wang, Jingmin
Zhang, Jiaosheng
Wu, Danxia
Xie, Gan
Shen, Kunling
Zheng, Yuejie
Yang, Yonghong
[J]. EXPERT REVIEW OF VACCINES, 2020, 19 (11) : 1093 - 1099
[40] Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
Shane Byrne
Andrew T Slack
[J]. BMC Infectious Diseases, 6

← 1 2 3 4 5 →